Loading organizations...
Loading organizations...
Key people at Novalis Biotech.
Novalis Biotech was founded by Jan Berghe (Managing Director & Co-Founder) and Wim van Criekinge (Co-Founder & Managing Director).
Novalis Biotech was founded by Jan Berghe (Managing Director & Co-Founder) and Wim van Criekinge (Co-Founder & Managing Director).
Key people at Novalis Biotech.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 4, 2026 | Alithea Genomics | $8.8M Seed | Genku Ventures | Jan Van den Berghe, Zürcher Kantonalbank |
| Jan 23, 2026 | Altavo | $3.5M Series A | bm|t, Novalis Biotech | High-Tech Grunderfonds, Ostwerk, Technologiegründerfonds Sachsen, TUDAG TU Dresden |
| Mar 1, 2024 | Alithea Genomics | $3.0M Seed | Jan Van den Berghe | 305 Ventures, ff Venture Capital, Mayfield, SOSV, Starbridge Venture Capital, TechU Angels, Ning Sung |
| Feb 20, 2024 | Altavo | $5.4M Series A | Mirco Müller | Michael Thiele, High-Tech Grunderfonds, Jaroslav Belotserkovsky, Saxonia Systems Holding, Soeren Schuster, TUDAG TU Dresden |
| Nov 2, 2022 | Enzyre | $11.9M Series A | Pieter Rhemrev | Demcon Investment, Karel Kubias, Takeda Ventures |
| Sep 7, 2022 | Carroucell | $1.5M Series A | Jan Van den Berghe | Bpifrance, Crédit Agricole |
| May 24, 2022 | Alithea Genomics | $1.0M Seed | Jan Van den Berghe | — |
| Jun 2, 2021 | RheaVita | $3.1M Series A | Kjell Mortier, Roald Borre | — |
| Feb 9, 2021 | GRAPHEAL | $2.3M Seed | Wim van Criekinge | — |
| Jul 27, 2020 | Enzyre | $1.6M Other Equity | Wim van Criekinge | — |
